Carlos García-Echeverría

Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent <i>in vivo</i> antitumor activity

Sauveur-Michel Maira, Frédéric Stauffer, Josef Brueggen et al. · Molecular Cancer Therapeutics · 2008 · 1.1K citations · Full text

Antitumor Activity of the Insulin-Like Growth Factor-I Receptor Kinase Inhibitor NVP-AEW541 in Musculoskeletal Tumors

Katia Scotlandi, Maria Cristina Manara, Giordano Nicoletti et al. · Cancer Research · 2005 · 295 citations

The Insulin-Like Growth Factor-I Receptor Kinase Inhibitor, NVP-ADW742, Sensitizes Small Cell Lung Cancer Cell Lines to the Effects of Chemotherapy

G. Sakuntala Warshamana-Greene, Julie Litz, Elisabeth Buchdunger et al. · Clinical Cancer Research · 2005 · 189 citations

Effects of the Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235 on the Tumor Vasculature: Implications for Clinical Imaging

Christian Schnell, Frédéric Stauffer, Peter R. Allegrini et al. · Cancer Research · 2008 · 174 citations

Immunology, Cancer Biology, Tumor Biology +17

Effect of P2′ substituents on kinetic constants for hydrolysis by cysteine proteinases

Carlos García-Echeverría, Daniel H. Rich · Biochemical and Biophysical Research Communications · 1992 · 13 citations

Kinetic Constants, Biochemistry, Natural Sciences +8